US Court Refuses Ranbaxy Laboratories Appeal To Block ANDA Nod For 2 Drugs

NEW DELHI: Drug firm Ranbaxy Laboratories today said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.

"The Court has not granted temporary restraining order to block FDA approval for other Abbreviated New Drug Applications (ANDAs) for generic version of Nexium and Valganciclovir," Ranbaxy Laboratories said in a filing to the BSE.

Help employers find you! Check out all the jobs and post your resume.

Back to news